FDA Limits Monoclonal Antibody Therapy

White House dismisses as ineffective treatment against COVID-19.

The FDA announced on Monday that it would be limiting the use of monoclonal antibody therapies in treating COVID-19. They were approved for use against the original strain, but are reportedly less effective against the variants.

Some politicians, such as Florida Gov. Ron DeSantis, were quick to oppose the decision. Governor DeSantis indicated his view that Americans’ access to treatments should not be subject to the whims of the president.

White House Press Press Secretary Jen Psaki stated the following day that proponents ”are still advocating for treatments that don’t work.” Ms. Psaki said, “We know what works, vaccines and boosters.”

As the Lord Leads, Pray with Us…

  • For the president’s administration to ensure that appropriate therapies are available to save lives and cure diseases.
  • For officials in the FDA as they research and assess treatments for various illnesses in addition to the coronavirus.
  • For leaders in government who endeavor to balance freedoms and rights against safety and control of public health.

Sources: The Hill, Reuters


Back to top